On September 2, 2015, Entia Biosciences Inc. and Devin Andres mutually agreed to the termination of Mr. Andres' position as Chief Operating Officer of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
2017 | Entia Biosciences, Inc. Announces Management Changes | CI |
2017 | Entia Biosciences, Inc Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 3.41T | |
+26.37% | 4.5TCr | |
-1.01% | 4.26TCr | |
+46.00% | 4.18TCr | |
-5.31% | 2.9TCr | |
+9.34% | 2.61TCr | |
-21.69% | 1.9TCr | |
+6.23% | 1.28TCr | |
+26.99% | 1.21TCr | |
-3.38% | 1.18TCr |
- Stock Market
- Equities
- ERGO Stock
- News Entia Biosciences, Inc.
- Entia Biosciences, Inc. Announces Termination of Devin Andres as Chief Operating Officer